Compositions and methods for sirna inhibition of icam-1

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A61K 31/713 (2006.01) A61K 48/00 (2006.01) C07H 21/02 (2006.01)

Patent

CA 2513623

RNA interference using small interfering RNAs which are specific for the ICAM- 1 gene inhibits expression of this gene. Diseases which involve ICAM-1- mediated cell adhesion, such as inflammatory and autoimmune diseases, diabetic retinopathy and other complications arising from type I diabetes, age related macular degeneration and many types of cancer, can be treated by administering the small interfering RNAs.

L'invention concerne l'utilisation d'ARN, notamment des ARN à faible intervention spécifiques au gène ICAM-1, qui permet d'inhiber l'expression de ce gène. Des maladies qui sont liées à l'adhérence cellulaire à médiation par ICAM-1 telles que les maladies inflammatoires ou auto-immunes, la rétinopathie diabétique et d'autres complications provoquées par le diabète de type I, la dégénérescence maculaire liée à l'âge et plusieurs types de cancer, peuvent être traités par l'administration d'ARN à faible intervention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for sirna inhibition of icam-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for sirna inhibition of icam-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for sirna inhibition of icam-1 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1983348

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.